Showing results (191-200 of 322) with videos related to

Sort By:
Pageof 33
Expert Review of Pharmacoeconomics & Outcomes Research|May 28, 2021
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in SpainFrancesc Formiga, Pablo García-Pavía, Francisco Javier Martín Sánchez, et al.
Revista Espanola De Geriatria Y Gerontologia|April 13, 2016
[Prevalence of sarcopenia in Spanish nursing homes: Comparison of the results of the ELLI study with other populations]Antoni Salvà, José Antonio Serra-Rexach, Iñaki Artaza, et al.
Age and Ageing|July 30, 2015
Prevalence of sarcopenia in patients attending outpatient geriatric clinics: the ELLI studyFederico Cuesta, Francesc Formiga, Alfonso Lopez-Soto, et al.
Internal and Emergency Medicine|January 6, 2019
Prevalence and outcome of diuretic resistance in heart failureJoan-Carles Trullàs, Jesús Casado, Jose-Luís Morales-Rull, et al.
Gaceta Sanitaria|August 4, 2016
[Characteristics of potentially inappropriate prescribing of drugs in elderly polypathological patients]Paula Carlota Rivas-Cobas, Nieves Ramírez-Duque, Mercedes Gómez Hernández, et al.
European Journal of Clinical Pharmacology|March 6, 2016
Elderly patients treated with psychotropic medicines admitted to hospital: associated characteristics and inappropriate useXavier Vidal, Antonia Agustí, Antoni Vallano, et al.
Postgraduate Medical Journal|January 8, 2016
The utility of heart failure registries: a descriptive and comparative study of two heart failure registriesJoan Carles Trullàs, Òscar Miró, Francesc Formiga, et al.
European Journal of Heart Failure|August 26, 2025
Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: A post-hoc analysis of the CLOROTIC trialAmbarish Pandey, Matthew W Segar, Neil Keshvani, et al.
Journal of Clinical Medicine|July 19, 2021
Predictive Factors of Pulmonary Embolism in Older Patients with SARS-CoV-2: The OCTA-COVID-19 StudyMaribel Quezada-Feijoo, Mónica Ramos, Isabel Lozano-Montoya, et al.
Frontiers in Cardiovascular Medicine|December 3, 2021
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A ReviewDomingo Pascual-Figal, Antoni Bayés-Genis, Paola Beltrán-Troncoso, et al.
Pageof 33